美股市场个股详情

CPRX Catalyst Pharmaceuticals

添加自选

15.880
-0.690-4.16%

收盘价 05/29 16:00 (美东)

16.090
+0.210+1.32%

盘后 19:12 (美东)

18.76亿总市值28.36市盈率TTM

Catalyst Pharmaceuticals股票讨论区

登录发表评论

Meltyy

05/24 16:20

See remaining FDA PDUFAs in May 👀👇
$施贵宝(BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US)$ : FIRDAPSE® (Amifampridine)
$葛兰素史克(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$再生元制药公司(REGN.US)$ : Kevzara (sarilumab)
$施贵宝(BMY.US)$ : Augtyro...

Trytosaveabit

05/09 04:21

Solid

$Catalyst Pharmaceuticals(CPRX.US)$ May 08 (Reuters) - Catalyst Pharmaceuticals Q1 Net Income USD 23.3 Million.
Q1 Adjusted Net Income USD 46.8 Million Vs. Ibes Estimate USD 23.7 Million
Q1 Operating Income USD 27.1 Million Vs. Ibes Estimate USD 25.1 Million
Outlook FY Revenue USD 455-475 Million

Moomoo AI

03/22 22:45

The absence of insider buying at Catalyst Pharmaceuticals over the past year is concerning. However, the high level of insider ownership indicates alignment with shareholder interests. Insider selling, even below the current price, raises questions about their view on the company's valuation.

Possible Bearish Signals With Catalyst Pharmaceuticals Insiders Disposing Stock

MARKET-TEST-DUMMY

01/29 08:24

hello?

$Catalyst Pharmaceuticals(CPRX.US)$ are you looking at me?

Moomoo AI

01/05 01:22

Investors are ostensibly keeping Catalyst Pharmaceuticals' P/E high due to expectations of its future growth surpassing the market. Currently, shareholders are confident in future earnings and do not foresee a significant dip in the share price in the near future.

Why Investors Shouldn't Be Surprised By Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) P/E

Moomoo AI

2023/12/13 18:58

While the level of insider ownership is robust, it is not outstanding. The recent insider selling without any corresponding insider buying over the past three months or the past year signals caution towards the company's stock.

Have Catalyst Pharmaceuticals Insiders Been Selling Stock?

Moomoo AI

2023/12/04 21:06

The CEO of Catalyst Pharmaceuticals expressed optimism about the appointment of Michael W. Kalb as new CFO and the promotions, which are expected to drive transformative contributions to the company's short and long-term growth.

Press Release: Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

Moomoo AI

2023/12/03 21:47

The previous sell-offs may present an opportunity to invest in Catalyst Pharmaceuticals given the long-term profit trajectory evident from their five-year performance. Nonetheless, investors are advised to consider the potential warning signs and other influential market conditions before making decisions.

Catalyst Pharmaceuticals (NASDAQ:CPRX) Increases 5.4% This Week, Taking Five-year Gains to 520%

72765352

2023/10/29 20:43

APLM Warrants price target of 11.50 found in 424B3 filing

$Apollomics(APLM.US)$
$盛德财富(PWM.US)$ $Guardforce AI(GFAI.US)$ $Intuitive Machines(LUNR.US)$ $Amesite(AMST.US)$ $Tenax Therapeutics(TENX.US)$ $Buzzfeed(BZFD.US)$ $COMSovereign(COMS.US)$ $Minerva Surgical(UTRS.US)$ $Ault Alliance(AULT.US)$ $尚乘数科(HKD.US)$ $Micromobility.com(MCOM.US)$ $Cadrenal Therapeutics(CVKD.US)$ $Genius Group(GNS.US)$ $BBBYQ$ $Cosmos Health(COSM.US)$ $Panbela Therapeutics(PBLA.US)$ $APGN$ $Annexon(ANNX.US)$ $金太阳健康科技(GSUN.US)$ $Laser Photonics(LASE.US)$ $Cemtrex(CETX.US)$ $Troika Media(TRKA.US)$ $NextPlay Technologies(NXTP.US)$ $惠普森医药(CPHI.US)$ $Dianthus Therapeutics(DNTH.US)$ $Nuwellis(NUWE.US)$ $OpGen(OPGN.US)$ $Powerbridge Technologies(PBTS.US)$ $Healthcare Triangle(HCTI.US)$ $Digital Brands Group(DBGI.US)$ $Kintara Therapeutics(KTRA.US)$ $Ensysce Biosciences(ENSC.US)$ $休斯敦能源(HUSA.US)$ $AlTi Global(ALTI.US)$ $Zovio(ZVOI.US)$ $Agrify(AGFY.US)$ $Oblong(OBLG.US)$ $SOBR Safe(SOBR.US)$ $Nauticus Robotics(KITT.US)$ $Avenue Therapeutics(ATXI.US)$ $Blue Apron(APRN.US)$ $Bright Minds Biosciences Inc(DRUG.CA)$ $Applied DNA Sciences(APDN.US)$ $智富融资(MEGL.US)$ $Evolve Transition Infrastructure(SNMP.US)$ $Vivos Therapeutics(VVOS.US)$ $American Strategic Investment(NYC.US)$ $Icecure Medical(ICCM.US)$ $Applied Uv(AUVI.US)$ $ShiftPixy(PIXY.US)$ $Tempest Therapeutics(TPST.US)$ $特百惠(TUP.US)$ $Applied Uv(AUVI.US)$ $Yield10 Bioscience(YTEN.US)$ $Assure(IONM.US)$ $Versus Systems(VS.US)$ $The Alkaline Water(WTER.US)$ $TC BioPharm(TCBP.US)$ $Unicycive Therapeutics(UNCY.US)$ $Peraso(PRSO.US)$ $PARTS iD(ID.US)$ $富时新加坡海峡指数(.STI.SG)$ $旭日升科技(ASTI.US)$ $Abri SPAC I(ASPA.US)$ $Connexa Sports Technologies(CNXA.US)$ $Unique Fabricating(UFAB.US)$ $Aditxt(ADTX.US)$ $PainReform(PRFX.US)$ $Alpha Technology(ATGL.US)$ $Urgent.ly(ULY.US)$ $Bruush Oral Care(BRSH.US)$ $ReShape Lifesciences(RSLS.US)$ $Appreciate Holdings(SFR.US)$ ...

Trytosaveabit

2023/10/27 04:17

LMAO!

$Catalyst Pharmaceuticals(CPRX.US)$ Amazing! a company gets a 3rd party to say its phase 2 data looks great, and that ticker explodes 300%? Then you have this and like $Ardelyx(ARDX.US)$ that get actual FDA approval and it dont move! hehehe so crazy! i mean i still think this does go? its just a matter of when?

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度